Su-Jun Park

Introduction: Su-Jun Park is a notable inventor based in Gyeonggi-do, South Korea. He has made significant contributions to the field of pharmaceuticals, holding a total of 8 patents. His work focuses on improving drug formulations for better patient compliance and efficacy.

Latest Patents: One of his latest patents involves a preparation comprising an inclusion complex of varenicline or its pharmaceutically acceptable salt for oral administration. This formulation aims to enhance the convenience of medication by effectively masking the bitter taste of the drug and minimizing irritation during swallowing. Additionally, it provides oxidation stability for varenicline and improves the drug's solubility. Another recent patent is a tadalafil free base-containing film dosage form that utilizes polyethylene glycol-based polymer and/or vinyl pyrrolidone-based polymer as a dispersion stabilizer. This film formulation maximizes the dispersion stability of tadalafil free base while minimizing the likelihood of reagglomeration and reducing bubble generation during production.

Career Highlights: Su-Jun Park has worked with prominent companies in the pharmaceutical industry, including CTC Bio, Inc. and Samsung SDI Co., Inc. His experience in these organizations has contributed to his expertise in drug formulation and development.

Collaborations: Throughout his career, Su-Jun Park has collaborated with talented individuals such as Bong-Sang Lee and Do-Woo Kwon. These partnerships have fostered innovation and advancement

This text is generated by artificial intelligence and may not be accurate.